Singapore markets closed

Coherus BioSciences, Inc. (CHRS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
12.59-0.13 (-1.02%)
At close: 04:00PM EST
12.42 -0.17 (-1.35%)
After hours: 06:59PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 1.29B
Enterprise value 1.24B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)3.62
Price/book (mrq)9.87
Enterprise value/revenue 3.41
Enterprise value/EBITDA -6.07

Trading information

Stock price history

Beta (5Y monthly) 0.92
52-week change 3-35.60%
S&P500 52-week change 314.07%
52-week high 322.22
52-week low 312.21
50-day moving average 316.81
200-day moving average 315.39

Share statistics

Avg vol (3-month) 3708.61k
Avg vol (10-day) 3972.82k
Shares outstanding 576.79M
Implied shares outstanding 6N/A
Float 863.58M
% held by insiders 12.03%
% held by institutions 1103.88%
Shares short (30 Dec 2021) 47.12M
Short ratio (30 Dec 2021) 49.81
Short % of float (30 Dec 2021) 413.06%
Short % of shares outstanding (30 Dec 2021) 49.27%
Shares short (prior month 29 Nov 2021) 47.14M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin -63.71%
Operating margin (ttm)-54.89%

Management effectiveness

Return on assets (ttm)-16.14%
Return on equity (ttm)-119.88%

Income statement

Revenue (ttm)363.6M
Revenue per share (ttm)4.89
Quarterly revenue growth (yoy)-27.30%
Gross profit (ttm)295.4M
EBITDA -196.12M
Net income avi to common (ttm)-231.67M
Diluted EPS (ttm)-3.12
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)468.71M
Total cash per share (mrq)6.1
Total debt (mrq)418.77M
Total debt/equity (mrq)320.26
Current ratio (mrq)2.10
Book value per share (mrq)1.71

Cash flow statement

Operating cash flow (ttm)48.01M
Levered free cash flow (ttm)-138.67M